{"url_path":"/sec/dtil/8-k/2026-07-01/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1357874/0001628280-26-046340-index.html","accession_number":"0001628280-26-046340","cik":"0001357874","ticker":"DTIL","issuer_name":"PRECISION BIOSCIENCES INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1357874/0001628280-26-046340-index.html","primary_entity_key":"0001357874","primary_entity_name":"PRECISION BIOSCIENCES INC"},"word_count":66,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d)Exhibits\n\nExhibit\nNo.Description\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document).\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nPRECISION BIOSCIENCES, INC.\n\nDate:July 1, 2026By:/s/ John Alexander Kelly\n\nJohn Alexander Kelly\n\nChief Financial Officer"}